Skip to content

Comparing the effectiveness of Acceptance-Based Behavioral Therapy and pharmacotherapy in Posttraumatic stress disorder (PTSD)

Comparing the effectiveness of Acceptance-Based Behavioral Therapy and pharmacotherapy in Posttraumatic stress disorder (PTSD)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170409033333N2
Enrollment
41
Registered
2018-01-24
Start date
2017-08-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post traumatic stress disorder (PTSD). Post-traumatic stress disorder (PTSD)

Interventions

Intervention 1: Intervention group: experimental group received ABBT in 12 individual sessions for 45 minutes, based on the guidelines for the development of the Roemer and Orsillo Psychological Disor
Behavior
Treatment - Drugs
Control group: The control group received only pharmacotherapy at the same time as the experimental group. Pharmacotherapy was supervised by the psychiatrist for both groups. Each group received 50 to
Intervention group: experimental group received ABBT in 12 individual sessions for 45 minutes, based on the guidelines for the development of the Roemer and Orsillo Psychological Disorders Protocol, w

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: the diagnosis of PTSD type of war the lack of psychological treatment for at least one month before entering the study having a minimum age of 18 and a maximum of 60 years and the ability to read and write

Exclusion criteria

Exclusion criteria: having psychotic symptoms and substance abuse having suicidal thoughts having severe personality disorders

Design outcomes

Primary

MeasureTime frame
The severity of the symptoms of PTSD. Timepoint: pretest and posttest. Method of measurement: questionnaire (Davidson Trauma Scale (DTS)).;Experiential avoidance. Timepoint: pretest and post test. Method of measurement: questionnaire ( Action and acceptance questionnaire (AAQ)).;Quality of life. Timepoint: pretest and post test. Method of measurement: questionnaire( Quality of life questionnaire (SF-36)).;Valued living questionnaire. Timepoint: pretest and post test. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadi ghaznafari

Iran University of Medical Sciences

ghazanfari.hadi67@gmail.com+98 21 6655 1616

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026